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Abstract The influence of netropsin (Nt), distamycin A (Dst-3) and chromomycin A, (CHR) on the binding of gyrase from Streptomyces noursei 
to an 162 bp-fragment of pBR 322 containing a strong gyrase cleavage site and on the gyrase mediated cleavage of this fragment was analyzed. Binding 
of the enzyme to the fragment is effectively inhibited by the GC-specilic drug CHR, but poorly influenced by Dst-3, while Nt is ineffective. Cleavage 
of the fragment catalysed by the enzyme is inhibited by all three ligands but to different extent. Dst-3 and Nt inhibit the enzyme cleavage reaction 
at 20- or 250-fold higher concentration than that required for CHR. The inhibitory mechanism of CHR on gyrase-DNA binding and cleavage may 
be related to a competitive interaction of the ligand to GC sequences located at and around the gyrase cleavage site. The fact that AT-specific minor 
groove binders Dst-3 and Nt poorly inhibit the binding of gyrase to the fragment due to the low amount of the AT basepair sequences contained 
in the fragment and their inhibitory in8uence on the cleavage step underlines the role of the DNA minor groove during enzyme action. 
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1. Introductloll 
DNA gyrase is a prokaryotic type II topoisomerase which 
catalyses the negative super-coiling of DNA [l-3]. The mecha- 
nism of DNA supercoiling by gyrase involves cleavage of DNA 
double strands, an ATP-driven passage of a DNA segment 
through the cleavage site and a religation step [4]. It has been 
shown that Gyr A is responsible for cleavage and religation, 
whereas Gyr B is involved in the ATP-dependent strand pas- 
sage step [4-6]. 
Gyrase is a target for two classes of antibiotics - the qui- 
nolones and the coumarins. Quinolones (e.g. ciprofloxacin) act 
on Gyr A [7] or on DNA in the enzyme complex [8] and 
coumarins act on Gyr B [7]. It has been recognized that the high 
antigyrase activity of quinolones observed for the E. coli en- 
zyme is not the same for other bacteria [9]. A very weak or no 
antigyrase effect on quinolones was observed for the enzymes 
from Streptomyces noursei [lo] and Micrococcus luteus [l 11. It 
was further shown that drugs which are DNA minor groove 
binders represent inhibitors of DNA gyrase in vitro [12]. Since 
a sequence specificity is known for several minor groove bind- 
ers [13] these agents can be regarded as useful probes in the 
elucidation of gyrase binding and cleavage sites on DNA. Dif- 
ferences in drug sensitivity of gyrases and the molecular mech- 
anism of their interference with the enzyme interaction on 
DNA is still an unsolved problem. In the present work we used 
purified subunits and the reconstituted enzyme from Strepto- 
myces noursei. For the analysis of the effect of minor groove 
binders on the binding and cleavage reaction of DNA gyrase 
a DNA fragment from pBR 322 was used as a substrate. 
2. Materials and methods 
2. I. Enzymes, DNA and liganris 
Isolation and purification of DNA gyrases was performed according 
to Staudenbauer and Orr [14]. In case of gyrase from Streptomyces 
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noursei a distinct modification of the procedure was required as de- 
scribed elsewhere [15]. 
The 162 bp fragment from pBR 322 consisting of the base pairs 936 
to 1097 was obtained by digestion with BglI and Suu3a. It contains a 
strong cleavage site for E. coli gyrase at base pair 990 [16]. 
Netropsin (Nt) was used as described previously [13], distamycin A 
(Dst-3) and chromomycin A, (CHR) were purchased from Serva (Hei- 
delberg) and Fluka, respectively. For chemical structures ee [13]. 
2.2. Gel retardation assay 
Binding of gyrase to the 162 bp fragment was detected by the mobil- 
ity-shift assay-using a 32P-end labelled DNA fragment in solution con- 
tain& 40 mM Tris CDH 7.51.19 mM KHPG.,. 34 mM KC1 and 3 mM 
MgCl; to achieve en&ne b’mding to DNA. Ligands were dissolved in 
distilled water and added to the assay mixture before enzyme addition. 
The mixture was incubated for 30 mm at 30°C. Samples were electro- 
phoresed in 5% polyacrylamide gels (3% cross-linking with bis- 
acrylamide) in 90 mM T&borate, pH 7.0, buffer containing 3 mM 
MgCl,. 
2.3. Cleavage assay 
Cleavage of the “P-end labelled 162 bp fragment was assayed in a 
buffer containing 50 mM Tris (PH 7.5), 55 mM KCl, 5 mM DTT, 4 mM 
MgC12 and 5% glycerol. 1OOpM ciprofloxacin (Bayer AG, Leverkusen) 
was added to prevent religation of the cleaved fragment. Samples were 
incubated 50 min at 30°C. SDS and proteinase K (Sigma) were added 
and incubated 30 min at 37°C. The reaction was terminated by EDTA 
and samples were deproteinized with an equal volume of phenol. The 
aqueous phase was applied to electrophoresis in a 7.5% (3% cross- 
linking) polyacrylamide gel in a 90 mM T&borate buffer, pH 7.0. 
3. Results 
3.1. Interaction of Streptomyces noursei gyrase with an 162 bp 
fragment 
DNA gyrase interaction with the 162 bp DNA fragment was 
demonstrated by using gel retardation assays. In presence of 
Mg2’ a discrete band is formed on polyacrylamide gels, which 
indicates complex formation between the fragment and gyrase. 
Fig. 1 shows the ability of gyrase from Streptomyces noursei to 
bind to this fragment, which contains the preferred gyrase 
cleavage site around nucleotide 990 known for E. coli gyrase 
[16,17]. Complex formation with native gyrase (A,Bd is 
achieved at a IO-12-fold molar excess of the enzyme-to-DNA 
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Fig. 1. Binding of Streptomyces gyrate to the 162 base pair fragment 
using the gel retardation assay (see section 2); DNA = 1 ng “P-1abelled 
162 bp fragment; * = amount of DNA from densitometrically inte- 
grated peak areas. 
whereas at 60-fold molar excess of the enzyme binding ap- 
proaches the saturation level (Fig. 1). 
Comparison of the binding of gyrases from Streptomyces 
noursei and E. coli shows that a 30-fold molar excess of the 
Streptomyces enzyme is necessary to bind 50% of the DNA, 
whereas already a 15-fold molar excess of the E. coli gyrase 
binds 50% of this DNA fragment. Therefore we can conclude 
that the strong binding site at nucleotide 990 of the fragment 
from pBR 322 is also a site for Streptomyces noursei gyrase 
although the aflinity of the E. coli gyrase to this site is two times 
higher. For comparison, completion of the transition of relaxed 
pBR 322 plasmid DNA into its supercoiled form mediated by 
Streptomyces gyrase requires a molar ratio of about 570-600 :1 
of DNA per enzyme (not shown). The Gyr A subunit alone, 
which is a very pure fraction [ 151, also forms a DNA-protein 
complex but at higher concentration (Fig. 2, lanes 3-6). Addi- 
tion of Gyr B to Gyr A favours binding of Gyr A to the 
fragment (Fig. 2, lanes lO--13), while Gyr B alone does not form 
a complex. 
Evidence for a specific complex formation of the enzyme 
with DNA can be shown to occur by applying competitor 
DNAs. As expected the native plasmid pBR 322 strongly inhib- 
its binding of gyrase to the 162 bp fragment whereas other 
DNA fragments, for instance the Epstein-Barr-Virus nuclear 
antigen binding region, were ineffective (data not shown). 
Using pBR 322 DNA devoid of the 162 bp fragment as a 
competitor, a 50-fold higher concentration of the unlabelled 
DNA over the labelled 162 bp fragment was required to achieve 
initial inhibition, a lOO-fold higher concentration for 50%, and 
a 200- fold higher concentration for the complete inhibition of 
the binding of Streptomyces noursei gyrase to the 162 bp frag- 
ment. Data for the E. coli enzyme are 6-, 15- and 56-fold higher 
concentrations of this competitor DNA for initial, 50% and 
complete inhibition, respectively. Since native pBR 322 is much 
more effective as competitor DNA the role for the affinity of 
Streptomyces gyrase to the 162 bp fragment is underlined. 
Using poly(dI-dC)-poly(dI-dC) as a competitor we found that 
a 200-fold higher concentration of this synthetic polymer over 
the labelled 162 bp fragment was required to achieve initial 
inhibition whereas a complete inhibition occurred only at 400- 
fold excess of the polymer (data not shown). These results 
suggest hat a specific interaction is involved in the Streptomy- 
ces gyrase complex formed with the 162 bp fragment. 
3.2. Effects of minor groove binders on gyrase activity and 
enzyme-DNA binding 
Based on indirect evidence nonintercalating agents may in- 
hibit gyrase activity by interaction in the minor groove of the 
DNA which probably blocks binding of the enzyme at the 
cleavage and religation site [12]. To obtain further insight into 
the mechanism of the interference of groove binders with the 
gyrase reaction we examined the effect of three sequence spe- 
ciflc DNA-ligands: Nt and Dst3, which both prefer AT base- 
pairs [13] and CHR A, which strongly prefers GC basepairs 
[18,19]. We have studied the influence of these DNA specific 
ligands on the enzyme binding to the 162 bp fragment contain- 
ing a gyrase site and on the gyrase mediated cleavage of this 
fragment that occurs in presence of ciprofloxacin. The pre- 
ferred cleavage site at basepair 990 known for the E. coli en- 
zyme must not be the same for the Streptomyces gyrase. 
However, from parallel assays with both enzymes analyzed 
on the same gel and from a gel electrophoretic analysis of the 
labelled ciprofloxacin induced cleavage fragment we assume 
that the cleavage site for Streptomyces gyrase must be located 
at or near basepair 990 (Fig. 3A). The quinolone-induced gy- 
rase cleavage reaction requires a much higher ciprofloxacin 
concentration for the Streptomyces enzyme [lo] compared to 
that of E. coli. 
For comparison the influence of Nt, Dst-3 and CHR on the 
ciprofloxacin-induced linearization of pBR 322 DNA as well 
as the effect of these ligands on the supercoiling reaction are 
included in Table 1. In agreement with previous data [ 121 these 
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Fig. 2. Binding of DNA gyrase subunits to the 162 base pair f agment 
using the nel r tardation assav (see section 2): DNA = 1 na 32P-labelled 
fra&ent;&bunits of gyrase f&m Streptom&es noursei. %e concentra- 
tions in lanes 10-13 correspond to constant amount of GyrA (upper 
row) and increasing amounts of GyrB (lower ow). 
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Fig. 3. Inhibition of the DNA gyrase mediated binding and cleavage 
of the 162 base pair fragment with CHR. Baud shift assay (Ianes l-9)
was done with 1 ng 32P-labelled fragment; DNA gyrase (reconstituted 
from subunits) from Strepromyces noursei 300 ng. Cleavage assay (lanes 
10-18) contained = 1 ng 32P-labelled fragment, subunits of DNA gyrase 
from S. noursei. Concentration ofCHR are nanomolar (nM). Electro- 
phoresis: see section 2. 
minor groove binders are effective inhibitors of the supercoiling 
reaction. From the present results it is evident that they affect 
especially the ciprofloxacin-induced cleavage to different ex- 
tent. The gyrase cleavage reaction is completely blocked by 
CHR at 10pM which corresponds to a total molar ratio, ligand 
per basepair r’ = 0.36 (Table 1). Nt inhibits the ciprofloxacin- 
induced linearization of the plasmid above 50 PM correspond- 
ing to a much higher ratio of r’ = 1.8. This indicates that the 
GC-specific CHR is virtually more potent to inhibit this reac- 
tion step than the AT-specific Nt. Dst-3 is also more effective 
than Nt, but it is somewhat less potent than CHR. 
Results of studies on the influence of these three minor 
groove binders on the binding and cleavage of the 162 bp 
fragment containing a single gyrase site are demonstrated in 
Figs. 3 and 4 and are summarized in Table 1. There is a large 
difference in the inhibitory effects on gyrase binding between 
Nt, Dst-3 on one hand and CHR on the other side. The dis- 
placement of gyrase from the DNA fragment induced by CHR 
occurs already at a final concentration of 30 nM of the ligand 
(Ii, Table 1) which corresponds to r’ of 1 (total ratio) and is 
complete at J of 2.6 (100 nM), whereas Nt and Dst-3 show an 
initial inhibitory effect at extremely high ligand concentration 
only (Fig. 4A, Table 1); i.e. CHR is about lO,OOO-fold more 
effective than Nt. 
Fig. 4B shows that in contrast to these binding data the 
gyrase mediated cleavage of the 162 bp fragment is effectively 
inhibited by all three ligands. The concentrations for initial, 
162 bp- 
107 bp- 
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Fig. 3. (A) cleavage of the 162 base pair f agment mediated by g rase 
from S. noursei (lanes l-4 = 10,25,40,80 ng enzyme, respectively) and 
E. coli (lanes 5-8 = 7.5, 15, 30, 50 ng enzyme, respectively). These 
results allow us to assume that the cleavage site of Streptomyces gyrase 
is located at orvery near to the E. coli gyrase site at base pair 990 (see 
Fig. 5). 
50% and complete inhibition for CHR are the same for the 
cleavage as well as for the binding step and suggest hat the 
ligand directly interferes with the enzyme binding and subse- 
quent cleavage reaction by interaction with the GC-preferred 
regions of the DNA. Dst-3 inhibits the cleavage of the fragment 
at 20-fold higher concentrations and Nt inhibits at 200-250- 
fold higher concentrations than CHR. Nevertheless, the inhib- 
itory concentrations of Nt on the cleavage of this specific gyrase 
site correlate with concentrations of this ligand which inhibit 
the overall supercoiling reaction of pBR 322. Dst-3 inhibits this 
specific site about 5-fold more effective than the overall super- 
coiling of the plasmid but CHR inhibits loo-fold stronger. The 
most striking differences in the behaviour of the three ligands 
we found in their influence on the binding of gyrase to the DNA 
fragment. 
4. Discussion 
In our present work we used the novobiocin-Sepharose puri- 
fied gyrase from Streptomyces noursei, its subunits and the 
reconstituted enzyme to investigate the interference of three 
minor groove binders with an active gyrase site contained in a 
DNA fragment. From these studies three aspects can be visual- 
ized: (i) Streptomyces gyrase binds selectively to the 162 bp 
fragment; (ii) the enzyme binding to its cleavage site is specifi- 
cally abolished by CHR but less by Dst-3 and not by Nt; and 
(iii) the ciprofloxacin induced cleavage of the fragment medi- 
ated by Streptomyces gyrase is preferentially inhibited by CHR, 
Table 1 
Influence of netropsin, distamycin A and chromomycin A, on the activity of DNA gyrase from Streptomyces 
Ligand Supercoiling of pBR 322 Linearization of pBR 322 Binding to the 162 bp-fragment Cleavage of the 162 bp-fragment 
ZM) $M) Z;M) ZM) ?M) kM) $M) $M) iM) t;;M) $M) ;M) 
Nt 30* 8* 2.5* 100 50 10 - 
300 
300 25 12 8 
Dst-3 10* 5* 1.5* 20 10 3 _ 50 2 1 0.8 
CHR 10* 5* 1* 10 5 1 0.1 0.06 0.03 0.1 0.06 0.03 
Ic, I,, and Ii = complete, 50% and initial inhibition; PM = final concentration of ligands, micromolar. 
*Compare data with [12]. 
- = inhibition could not be found up to 1 mM concentration of ligands. 
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Fig. 4. (A) Inhibition of the binding of gyrase from Streptomyces 
noursei to the 162 bp fragment by ligancls. Final concentration of 
ligands means micromolar concentration i the assay (circles); CHR, 
squares; Nt, triangles; Dst-3, amount of free DNA derived from den- 
sitometrically integrated Peak areas. DNA = 1 ng 3ZP-labelled frag- 
ment. (B) Inhibition of the gyrase mediated cleavage of the 162 bp 
fragment by ligands. Final concentration fligands means micromolar 
at which ligands how complete (dark grey), 50% (black) or initial (light 
grey) inhibition of the ciprofloxacin-mediated cl avage. DNA = 1 ng 
32P-labelled fragment. 
20-fold less by Dst3 and 200-fold less by Nt. It should be 
mentioned that we assigned the cleavage site of Streptomyces 
gyrase to the 990 base pair position as known for the E. coli 
enzyme, since the size of the ciprofloxacin-induced cleavage 
fragment justifies this assumption. 
Dst-3 and Nt can quite effectively inhibit the supercoiling 
and cleavage reaction of gyrase when the plasmid is used as a 
substrate, but (Table 1) they are nearly ineffective to prevent 
binding of the enzyme to the DNA fragment (Fig. 4A). The 
pronounced inhibitory effect of the minor groove binder CHR 
on the binding of gyrase and cleavage of the fragment by gyrase 
suggests that these reaction steps, mediated by the Gyr A pro- 
tein, are directly blocked by interaction of the drug with GC- 
sequences (Fig. 5) in the minor groove. The lower effectiveness 
of Dst-3 and the inability of Nt to compete with gyrase binding 
on the 162 bp fragment is most probably related to the small 
number of AT affinity sites at and around the gyrase cleavage 
site (Fig. 5). Strong binding of Dst-3 and Nt will occur prefer- 
entially on AT clusters [13]. Since about 120 base pairs of DNA 
are wound around the native enzyme tetramer AzBz [25], it is 
plausible that only one or a few ligand molecules competing on 
AT clusters at a distance from the cleavage center are insutli- 
cient to prevent binding of the enzyme. In contrast, CHR as a 
CC-specific agent displaces gyrase at rather low concentration 
from the 162 bp fragment (Fig. 3) due to numerous specitic GC 
sites present in this DNA fragment. We tested in a mobility shift 
assay the affmity of the ligands to the 162 bp fragment (in the 
absence of the enzyme) and measured a significant retardation 
of the DNA fragment (in 8% polyacrylamide, 5% cross-linked 
with bis-acrylamide) in presence of 2 PM CHR whereas Nt and 
Dst-3 even at 1 mM showed no or only a weak retardation 
effect (data not shown). CHR binding to GC sequences in the 
minor groove requires MC ions [ 18-211. 
NMR [ 191 and footprinting data [ 18,201 showed that in pres- 
ence of Mg2+ CHR binds as a dimer to the central sequence 
STGGCC of an octanucleotide and of an l&mer with a bind- 
ing constant of 2.7 x 10’ M-i [18]. This central sequence re- 
ported for a strong site of CHR is identical with the recognition 
and cleavage site of gyrase in the 162 bp fragment (Fig. 5). Thus 
we propose that CHR strongly competes at the cleavage site of 
gyrase and in the surrounding GC-rich regions. NMR measure- 
ments further revealed that binding of the CHR dimer to the 
sequence GGCC causes a modification of the groove width 
resulting in an A-like conformation [19]. This conformational 
change can drastically diminish the enzyme affinity constant 
which additionally prevents gyrase binding. In contrast to that 
Nt and Dst-3 are inserted into the minor groove of B-DNA with 
a minimal change in groove width [22]. It has been argued that 
intrinsic curvature of DNA surrounding the regions of the 990 
site of pBR 322 could be an essential factor responsible for the 
preference of gyrase binding and cleavage of this site [23]. On 
the other hand, it was shown by X-ray crystal structure analysis 
of the decamer CATGGCCATG that a curvature occurs over 
the GGCC center [24]. It seems possible that this intrinsic bend 
compressing the major groove is a local structural element 
which could promote the enzyme mediated cleavage. Minor 
groove binding of CHR to the GGCC center abolishes DNA 
curvature which may be another feature of the inhibitory effect. 
The CHR-induced inhibition is also a reflection of the drug 
binding in surrounding sequences, since in the gyrase DNA 
complex a DNA segment of about 120 base pairs is occupied 
by the protein [25]. This may be the reason that Nt and Dst3, 
which have a strong binding site at a 10 bp distance from the 
cleavage site (Fig. 5, AT-cluster 1001-1005) do not prevent the 
binding of gyrase to the fragment, but both drugs influence the 
TGGCG =GACGCGC TGGGCTACGT 
CTTGCTGGC? TTCGCGACG? GAGGCTGGAy+ 
GGCC’ITCCC? ~TT??TGA&?_ _ TTCTCGCTT? 
CGGCGGCA;; GGGATGCCC: CGTTGCAG 
CATGCTGT;?? AGGCAGG$;_ _ ATGACGAC;: 
TCAGGGAC;: m_GfiG 
1070 i-ii 
1m 
Fig. 5. Sequence of the 162 bp fragment from pBR 322 (see section 2), 
GC content = 64 mol%. Suggested strong binding sites for CHR (=), 
possible strong and weak binding sites for Nt and Dst-3 (-----), specific 
gyrase cleavage site at AT,, (see arrow). 
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cleavage step of the enzymatic reaction. Dst3 inhibits the cleav- 
age 10 times more effective than Nt. We explain this fact with 
possible binding of Dst3 molecules e.g. at the nucleotides 
1007-1012 and 10681072. At regions consisting of AT- and 
GC-basepairs Dst3 will bind with a higher probability [13,26] 
than Nt does resulting in a higher inhibitory efficiency of Dst3 
(Fig. 4B). This implies that the enzyme is still bound to its 
substrate DNA but is prevented to cleave when a few minor 
groove binders block sequences in surrounding regions of the 
cleavage center. Therefore it is quite possible that a higher 
number of AT-clusters in the vicinity of a gyrase site can lead 
to a strong competitive binding effect of Nt and Dst3. This 
could be anticipated since the inhibitory effect on the supercoil- 
ing activity of Streptomyces gyrase differs not significantly be- 
tween these AT-selective ligands and CHR (Table 1, [12]), 
which awaits, however, further investigation. 
Our results show that sequence specific minor groove bind- 
ers, such as CHR can probe the recognition site of gyrase as 
also demonstrated for restriction endonucleases [13,27,28]. This 
could reflect the role of the minor groove for the gyrase-DNA 
interaction. Although DNA sequence recognition by proteins 
preferably occurs in the major groove [29], in some cases the 
minor groove is involved in DNA protein interaction; e.g. 
minor groove contacts have been shown to exist for DNase I 
binding to DNA [30] and for a binding domain of Hin recom- 
binase [3 11. Whether in the process of gyras+DNA interaction 
and cleavage the minor or major groove or both play a role for 
contacts with domains of the Gyr A protein cannot be con- 
cluded from the present data. 
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